chr17-17212475-T-TA
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_144997.7(FLCN):c.*1179dupT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.063 ( 600 hom., cov: 19)
Exomes 𝑓: 0.00094 ( 0 hom. )
Consequence
FLCN
NM_144997.7 3_prime_UTR
NM_144997.7 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.602
Genes affected
FLCN (HGNC:27310): (folliculin) This gene is located within the Smith-Magenis syndrome region on chromosome 17. Mutations in this gene are associated with Birt-Hogg-Dube syndrome, which is characterized by fibrofolliculomas, renal tumors, lung cysts, and pneumothorax. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
MPRIP (HGNC:30321): (myosin phosphatase Rho interacting protein) Enables cadherin binding activity. Predicted to be involved in actin filament organization. Located in actin cytoskeleton and cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLCN | ENST00000285071 | c.*1179dupT | 3_prime_UTR_variant | Exon 14 of 14 | 1 | NM_144997.7 | ENSP00000285071.4 | |||
ENSG00000264187 | ENST00000427497.3 | n.*372+2509dupT | intron_variant | Intron 9 of 11 | 1 | ENSP00000394249.3 | ||||
MPRIP | ENST00000578209.5 | c.*18-4989dupA | intron_variant | Intron 5 of 5 | 3 | ENSP00000464276.1 |
Frequencies
GnomAD3 genomes AF: 0.0633 AC: 4742AN: 74866Hom.: 600 Cov.: 19 show subpopulations
GnomAD3 genomes
AF:
AC:
4742
AN:
74866
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000936 AC: 1AN: 1068Hom.: 0 Cov.: 0 AF XY: 0.00187 AC XY: 1AN XY: 536 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
1068
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
536
Gnomad4 AFR exome
AF:
AC:
0
AN:
36
Gnomad4 AMR exome
AF:
AC:
0
AN:
20
Gnomad4 ASJ exome
AF:
AC:
0
AN:
54
Gnomad4 EAS exome
AF:
AC:
0
AN:
376
Gnomad4 SAS exome
AF:
AC:
0
AN:
10
Gnomad4 FIN exome
AF:
AC:
0
AN:
2
Gnomad4 NFE exome
AF:
AC:
1
AN:
494
Gnomad4 Remaining exome
AF:
AC:
0
AN:
72
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0634 AC: 4748AN: 74892Hom.: 600 Cov.: 19 AF XY: 0.0628 AC XY: 2156AN XY: 34308 show subpopulations
GnomAD4 genome
AF:
AC:
4748
AN:
74892
Hom.:
Cov.:
19
AF XY:
AC XY:
2156
AN XY:
34308
Gnomad4 AFR
AF:
AC:
0.190688
AN:
0.190688
Gnomad4 AMR
AF:
AC:
0.0327532
AN:
0.0327532
Gnomad4 ASJ
AF:
AC:
0.0344498
AN:
0.0344498
Gnomad4 EAS
AF:
AC:
0.00879567
AN:
0.00879567
Gnomad4 SAS
AF:
AC:
0.0386082
AN:
0.0386082
Gnomad4 FIN
AF:
AC:
0.00217707
AN:
0.00217707
Gnomad4 NFE
AF:
AC:
0.022007
AN:
0.022007
Gnomad4 OTH
AF:
AC:
0.0649351
AN:
0.0649351
Heterozygous variant carriers
0
164
328
491
655
819
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Spontaneous pneumothorax Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Birt-Hogg-Dube syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at